Promote Sponsor
verified SJR 1,137 · Q2 • database Scopus / SJR & Web of Science indexed
Human Gene Therapy
United States · Mary Ann Liebert Inc.
workspace_premium Q2 — Molecular Biology lock Subscription Unclaimed

Human Gene Therapy

Human Gene Therapy is a journal indexed in SJR in Molecular Biology and Genetics with an H index of 163. It has an SJR impact factor of 1,137 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,137.

Human Gene Therapy focuses its scope in these topics and keywords: gene, cell, vector, virus, type, human, therapy, expression, transfer, april, ...

ISSN: 1043-0342
Editorial: Mary Ann Liebert Inc.
Category: Molecular Biology
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
1,137 Q2
H-index 163
Tasa de Aceptación pie_chart
21% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
NPD Subscription
Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

1,137

H-index

163

Docs (year)

87

Docs 3y

414

Total refs

4311

Cites 3y

1286

Citable 3y

376

Cites/Doc 2y

3.29

Ref/Doc

49.55

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Opinion Paper on the Current Status of the Regulation of Gene Therapy in Europe

View more

What Is Suppression of Anti-Adeno-Associated Virus Capsid T-Cells Achieving?

View more

Transduction of Human Islets with Pseudotyped Lentiviral Vectors

View more

Systemic and Persistent Muscle Gene Expression in Rhesus Monkeys with a Liver De-Targeted Adeno-Associated Virus Vector

View more

Synthetic Messenger RNA as a Tool for Gene Therapy

View more

Successful Gene Therapy via Intraarticular Injection of Adenovirus Vector Containing CTLA4IgG in a Murine Model of Type II Collagen-Induced Arthritis

View more

Stimulation of Reparative Dentin Formation by Ex Vivo Gene Therapy Using Dental Pulp Stem Cells Electrotransfected with Growth/differentiation factor 11 (Gdf11)

View more

The Current Status of Clinical Gene Therapy

View more

Potential of Atelocollagen-Mediated Systemic Antisense Therapeutics for Inflammatory Disease

View more

Partial Prevention of Cisplatin-Induced Neuropathy by Electroporation-Mediated Nonviral Gene Transfer

View more

Partial Correction of Sensitivity to Oxidant Stress in Friedreich Ataxia Patient Fibroblasts by Frataxin-Encoding Adeno-associated Virus and Lentivirus Vectors

View more

Osteoinduction by Bone Morphogenetic Protein 2-Expressing Adenoviral Vector: Application of Biomaterial to Mask the Host Immune Response

View more
SHOW MORE ARTICLES

Preclinical Dose-Escalation Study of Intravitreal AAV-RS1 Gene Therapy in a Mouse Model of X-linked Retinoschisis: Dose-Dependent Expression and Improved Retinal Structure and Function

View more

Novel Bidirectional Vector Strategy for Amplification of Therapeutic and Reporter Gene Expression

View more

Nonviral Gene Transfer into Liver and Muscle for Treatment of Hyperbilirubinemia in the Gunn Rat

View more

Nonionic Amphiphilic Block Copolymers Promote Gene Transfer to the Lung

View more

Nitroprusside Increases Gene Transfer Associated with Intracoronary Delivery of Adenovirus

View more

Neuroprotective Gene Therapy for Huntington's Disease, Using Polymer-Encapsulated Cells Engineered to Secrete Human Ciliary Neurotrophic Factor: Results of a Phase I Study

View more

Neurodegeneration Augments the Ability of Bone Marrow-Derived Mesenchymal Stem Cells to Fuse with Purkinje Neurons in Niemann-Pick Type C Mice

View more

Monogene and Polygene Therapy for the Treatment of Experimental Prostate Cancers by Use of Apoptotic Genes bax and bad Driven by the Prostate-Specific Promoter ARR2PB

View more

Modulation of Eomes Activity Alters the Size of the Developing Heart: Implications for In Utero Cardiac Gene Therapy

View more

Mitochondrial Gene Therapy Augments Mitochondrial Physiology in a Parkinson's Disease Cell Model

View more

Micro-Dystrophin Gene Therapy Goes Systemic in Duchenne Muscular Dystrophy Patients

View more

Low-Level Tyrosine Hydroxylase (TH) Expression Allows for the Generation of Stable TH+ Cell Lines of Human Neural Stem Cells

View more

FAQS